Carmen Navarrete-Sirvent

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 10, 2025
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.

Carmen Navarrete-Sirvent, Ana Mantrana, Aurora Rivas-Crespo

Pageof 1